A detailed history of First Trust Advisors LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 158,825 shares of FOLD stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
158,825
Previous 33,355 376.17%
Holding current value
$1.56 Million
Previous $330,000 413.94%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$9.55 - $12.09 $1.2 Million - $1.52 Million
125,470 Added 376.17%
158,825 $1.7 Million
Q2 2024

Aug 13, 2024

SELL
$9.04 - $11.75 $2.59 Million - $3.36 Million
-286,313 Reduced 89.57%
33,355 $330,000
Q1 2024

May 13, 2024

BUY
$11.43 - $14.24 $2.33 Million - $2.9 Million
203,422 Added 174.99%
319,668 $3.77 Million
Q4 2023

Feb 13, 2024

SELL
$9.97 - $14.52 $2.06 Million - $3 Million
-206,440 Reduced 63.98%
116,246 $1.65 Million
Q3 2023

Nov 13, 2023

BUY
$11.78 - $13.86 $3.68 Million - $4.33 Million
312,508 Added 3070.43%
322,686 $3.92 Million
Q2 2023

Aug 14, 2023

SELL
$10.72 - $13.3 $2.1 Million - $2.61 Million
-196,091 Reduced 95.07%
10,178 $127,000
Q1 2023

May 15, 2023

SELL
$10.91 - $13.54 $106,688 - $132,407
-9,779 Reduced 4.53%
206,269 $2.29 Million
Q4 2022

Feb 09, 2023

SELL
$9.89 - $12.7 $691,657 - $888,174
-69,935 Reduced 24.45%
216,048 $2.64 Million
Q3 2022

Nov 14, 2022

BUY
$9.82 - $12.75 $1.49 Million - $1.93 Million
151,631 Added 112.86%
285,983 $2.99 Million
Q2 2022

Aug 12, 2022

BUY
$6.23 - $11.12 $66,411 - $118,539
10,660 Added 8.62%
134,352 $1.44 Million
Q1 2022

May 13, 2022

SELL
$7.89 - $12.48 $352,967 - $558,305
-44,736 Reduced 26.56%
123,692 $1.17 Million
Q4 2021

Feb 08, 2022

BUY
$9.82 - $12.44 $1.65 Million - $2.1 Million
168,428 New
168,428 $1.95 Million
Q2 2021

Aug 16, 2021

SELL
$8.71 - $10.72 $2.51 Million - $3.09 Million
-288,291 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$9.2 - $23.86 $174,128 - $451,598
18,927 Added 7.03%
288,291 $2.85 Million
Q4 2020

Feb 02, 2021

BUY
$13.47 - $24.89 $1.37 Million - $2.53 Million
101,814 Added 60.77%
269,364 $6.22 Million
Q3 2020

Nov 05, 2020

SELL
$12.89 - $15.89 $32,070 - $39,534
-2,488 Reduced 1.46%
167,550 $2.37 Million
Q2 2020

Jul 22, 2020

BUY
$8.86 - $15.69 $388,865 - $688,634
43,890 Added 34.79%
170,038 $2.56 Million
Q1 2020

May 06, 2020

BUY
$6.63 - $11.16 $734,855 - $1.24 Million
110,838 Added 723.96%
126,148 $1.17 Million
Q4 2019

Feb 03, 2020

SELL
$7.48 - $10.75 $638,702 - $917,921
-85,388 Reduced 84.8%
15,310 $149,000
Q3 2019

Nov 04, 2019

SELL
$8.02 - $13.25 $1.15 Million - $1.91 Million
-143,852 Reduced 58.82%
100,698 $808,000
Q2 2019

Jul 30, 2019

BUY
$10.96 - $14.4 $2.17 Million - $2.85 Million
197,880 Added 424.0%
244,550 $3.05 Million
Q1 2019

May 09, 2019

BUY
$10.04 - $13.92 $468,566 - $649,646
46,670 New
46,670 $635,000
Q4 2018

Feb 07, 2019

SELL
$8.38 - $13.44 $1.79 Million - $2.87 Million
-213,396 Closed
0 $0
Q3 2018

Oct 25, 2018

BUY
$11.6 - $16.54 $336,933 - $480,420
29,046 Added 15.76%
213,396 $2.58 Million
Q2 2018

Aug 02, 2018

BUY
$13.13 - $17.09 $282,071 - $367,144
21,483 Added 13.19%
184,350 $2.88 Million
Q1 2018

Apr 23, 2018

BUY
$13.76 - $17.12 $2.24 Million - $2.79 Million
162,867 New
162,867 $2.45 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.75B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.